Mayo Clinic Arizona Guidelines for Prevention and Surveillance of Colorectal Cancer
Division of Gastroenterology Colorectal Neoplasia Clinic
Screening/Prevention (Table 1)
Patient Category First Step Next Step Reference
Average risk patient, no risk factors for colorectal cancer except age 50 years
|
Begin screening colonoscopy at age 50
|
If normal repeat every 10 years
|
AGA1, ACS², ACG³
|
Average risk patient, no risk factors for colorectal cancer except race (African American)
|
Begin screening colonoscopy at age 45
|
If normal repeat every 10 years
|
ACG6
|
Single 1st-degree relative* with colorectal cancer dx age 60 or two 2nd degree* relatives dx with colorectal cancer
|
Begin screening colonoscopy at age 40.1,3
|
If normal, repeat every 5-10 years3,4
|
AGA1, ACG³,4
|
Single 1st-degree relative with colorectal cancer or tubular adenoma 60 years or two 1st-degree relatives of any age |
Colonoscopy at age 40, or 10 years before the youngest case in the 1st-degree relative, whichever comes first
|
If normal, repeat every 5 years
|
AGA1, ACG³,4
|
Inflammatory bowel disease, chronic UC or Crohn’s disease
|
Screening colonoscopy 8 years after onset of pancolitis, or 12-15 years after onset of left sided-colitis
|
Every 1-2 years
|
AGA1, ACS², ACG³
|
For patients with colorectal cancer before age 50, multiple polyps before age 40 or with a family hx of colorectal or other cancers, consider a hereditary colorectal cancer syndrome |
Call Genetic Counseling @ (480) 301-4585 or any member of the Colorectal Interest Group: Drs. Heigh, Leighton, Efron, Heppell, and Young Fadok |
|
MCA Genetic Counseling Consensus
|
Discontinuation of surveillance colonoscopy should be considered in patients with serious co-morbidities with less than 10 years of life expectancy, according to the clinician’s judgment.
|
Consider alternative to colonoscopy for colorectal cancer prevention or surveillance
|
Follow up is dependent on results of screening.
|
AGA
|
Surveillance (Table2)
Patient Category First Step Next Step Reference
1 to 2 adenomas, < 1cm
|
5–10 years; precise timing within this interval should be based on other clinical factors such as prior colonoscopy findings, family hx etc.
|
If normal, repeat every 10 years
|
AGA7
|
• 3 adenomas •Adenoma with villous or serrated histology •1 adenoma> 1 cm •Hyperplastic polyp >1 cm is treated as adenoma
|
Repeat in 3 years if confident all adenomas have been found and resected
|
If normal, repeat in 5 years
|
AGA1,7, ACG4
|
Large sessile (no stalk) adenoma >2 cm
|
Repeat in 3 months5
|
If residual polyp removed, repeat in 6mos.4 If either of previous exams are normal, repeat in 1 year. If normal after 1 year, repeat every 3 years.5 If not normal after 2-3 exams then surgery.4,5
|
ACG4 GI Endoscopy5
|
Adenoma with high grade dysplasia or malignant polyp completely resected with clear margins of excision and no invasion of stalk. Adjust for individual patient characteristics including fitness for and interest in considering additional treatment
|
If polyp is pedunculated, strongly consider GI or colorectal surgery consultation. Repeat colonoscopy in 3 years.
|
If normal, repeat in 5 years if it is the only polyp.
|
ACG4
|
If polyp is sessile, strongly consider GI or colorectal surgery consultation for further diagnosis and treatment or consider repeating colonoscopy or flex-sig in 3 months 4
|
Follow up based on consultation or consider repeat colonoscopy or flexsig at 3-6 mos.
|
ACG4
|
|
Personal history of curative intent resection of colorectal cancer and surveillance after curative intent treatment for colorectal cancer:
|
•Repeat colonoscopy six months to one year after cancer resection. •H&P every 3-6 months x 3 years •Annual CT chest, abdomen and pelvis x 3 years •CEA every 3 months for 3 years •Flex-sig every 6 months for rectal cancers not treated with XRT
|
•H&P every 6 months years 4 and 5
|
ASCO8
|
If conflict between table 1 and table 2, choose the earlier time. Individual
situations may dictate a course of management at variance from these guidelines.
Preferred Procedure
Colonoscopy 1, 2, 6 particularly in African Americans
Alternative Strategies:
• Fecal occult blood testing (FOBT) plus flexible sigmoidoscopy with
contrast barium enema
1. Three stool samples collected by patient after a bowel movement 1
2. Strict instructions regarding diet/medications prior to stool
Collections
Indications for Colonoscopy:
• Colon cancer screening and surveillance of colonic neoplasia 9
• Evaluation of unexplained gastrointestinal bleeding e.g.
hematochezia, melena after upper GI source has been ruled out,
positive FOBT and treatment of known GI bleeding lesion 9
• Abnormality of the colon on imaging study e.g. filling defect on
barium enema 9
• Unexplained iron deficiency anemia 9
• Patients with significant family history i.e. hereditary non polyposis
colorectal cancer
• History of inflammatory bowel disease 9
• Foreign body removal 9
• Balloon dilation of stenotic lesion 9
• Decompression of acute nontoxic megacolon or sigmoid volvulus 9
• Marking neoplasm for localization 9
• Clinically significant diarrhea of unexplained origin 9
• Excision of colonic polyp 9
• Change in bowel habits
Colonoscopy Generally Not Indicated for These Symptoms and
Diagnoses:
• Chronic, stable irritable bowel syndrome 9
• Chronic abdominal pain; 9 consider contrast barium enema if
warranted
• Acute diarrhea i.e. diarrhea for less than 3 weeks 9
• Metastatic adenocarcinoma of unknown primary site in the absence
of colonic signs & symptoms when it will not influence management9
• Upper GI bleeding or melena with a demonstrated upper GI source 9
• Chronic constipation; consider contrast barium enema if warranted
• Cancer other than colon cancer e.g. prostate cancer, breast cancer
which does not apply if Lynch Syndrome suspected
PREP CONSIDERATIONS
Mayo Clinic Arizona Standard Preps: 4 liter lavage with balanced electrolyte solutions & PEG:
TriLyte, NuLytely, Colyte, Go-Lytely. Studies show absence of Na sulfate in Trilyte and NuLytely
have better taste.
Optional 2 Liter Lavage: Half-Lytely (balanced electrolytes & PEG plus 4 bisacodyl tablets, Na
sulfate free). Requires a RX from referring MD.
Available Sodium Phosphate Preparations: Fleets Phospho Soda, or OsmoPrep Tablets
Warning for Sodium Phosphate Preps: Extreme caution in renal insufficiency
(CCr<30ml/min), underlying electrolyte disorders, ascites, CHF, unstable angina, arrhythmias,
post GI bypass. Rare reports of renal failure, acute phosphate nephropathy, and seizures
exist. Consider baseline and post colonoscopy labs in those at risk of electrolyte disorders
or complications from electrolyte disorders. Not for use in evaluating diarrhea or IBD.
Patients taking sodium phosphate preps must obtain referring MD’s consent and a RX for
OsmoPrep.
Contraindications for all Preps: obstruction, ileus, gastric retention, possible perforation,
toxic colitis, megacolon.
Prep Timing: For AM exam: 4:00 PM afternoon prior; for PM exam: Morning of exam
preferred, 4:00 PM afternoon prior acceptable if necessary.
Directions for all Preps: Day prior to exam – Clear liquids all day until 3 hours prior to exam.
4 LITER LAVAGE Directions: 4:00 PM day prior drink 8oz prep every 10 minutes until prep is
consumed.
2 LITER LAVAGE Directions: 12:00 PM day prior take 4 bisocodyl tablets. After bowel
movement, but no later than 6:00 PM, drink 8oz prep every 10 minutes until prep is
consumed.
PHOSPHO SODA Directions: 4:00 PM day prior - mix 1 1⁄2 oz of prep in 12oz water and drink,
followed immediately by 12oz water. Drink an additional minimum 24oz water that evening.
4:00 AM day of procedure mix 1oz prep in 12oz water and drink. Follow immediately with
12oz water.
OSMOPREP Directions: 4:00 PM day prior take 4 tablets with 8 oz clear liquid every 15
minutes until 20 tablets are consumed. 4:00 AM day of procedure take 4 tablets every 15
minutes until the remaining 12 tablets are consumed.
________________________________________________________________________________________
1 Winawer S,et al; Gastrointestinal Consortium Panel. Colorectal cancer screening and
surveillance: clinical guidelines and rationale-update based on new evidence.
Gastroenterology. 2003 Feb;124(2):544-60
2 ACS-American Cancer Society
3 ACG-American College of Gastroenterology on Colorectal Cancer Screening for
Average and Higher Risk Patients in Clinical Practice. 2000
4 Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with
colorectal polyps. Am J Gastroenterol. 2000 Nov;95(11):3053-63
5 Brooker JC, et al; Treatment with argon plasma coagulation reduces recurrence after
piecemeal resection of large sessile colonic polyps: a randomized trial and
recommendations. Gastrointest Endosc. 2002 Mar;55(3):371-75
6 Agrawal S, Bhupinderjit A, Bhutani MS, Boardman L, Nguyen C,et al; Committee of Minority
Affairs and Cultural Diversity, American College of Gastroenterology. Colorectal cancer in
African Americans. Am J Gastorenterol. 2005 Mar;100(3):515-23
7 Winawer S, et al; American Gastroenterological Association. Guidelines for colonoscopy
surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on
colorectal cancer and the American Cancer Society. Gastroenterology
2006;May130(6):1872-85
8 Desch CE, et al; Colorectal cancer surveillance: 2005 update of an American
Society of Clinical Oncology practice guideline. J Clin Oncol. 2005
Nov;23(33):8512-19
9 ASGE-American Society for Gastrointestinal Endoscopy
• 1st-degree relative is parent, sibling, or child. 2nd-degree relative is grandparent,
uncle/aunt, or cousin
Revised 7-2006 ITCFranklinGothicStd-Book
Mayo Clinic Arizona Standardized Colon Prep Grading For All Colonoscopies
Excellent: minimal amount of debris not hindering proper adequate
visualization.
Good: some liquid debris not significantly interfering with the exam.
Fair Adequate: moderate amount of liquid debris, or minimal amount of
solid debris to prevent a completely reliable exam. After adequate
intraprocedure cleansing, endoscopist confident that lesions over 1 cm
have been detected.
Fair Inadequate: large amounts of liquid, or moderate to large amounts
of solid debris with inadequate visualization of colon. After adequate
intraprocedure cleansing, endoscopist not confident that lesions over
1 cm have been detected.
Poor: solid debris limits nearly entire exam.
Suggested Standard Clinical Recommendations For Prevention/
Screening and Most Surveillance Examinations Based on Prep
Grading*
Excellent: Standard published guidelines
Good: Standard published guidelines
Fair Adequate: standard published guidelines
Fair Inadequate: For appropriate patients who have never had a prior
colon colorectal cancer prevention examination, the examination should
be repeated without delay. Otherwise, for appropriate patients without
signs or symptoms, follow up colonoscopy may be deferred for 1 to 2
years.
Poor: Colon insufficiently evaluated; reexamination by some method
should be considered based on clinical circumstances and patient/referring
physician preferences
*SPECIAL NOTES:
1.Only excellent or good prep ratings are acceptable for patients
with signs or symptoms who are scheduled for Diagnostic
Examinations. Other prep grades warrant individual decision making
based on clinical circumstances.
2.Patients who have significant problems with constipation, motility
issues, or a prior history of inadequate colonoscopy preparation, will
require a minimum two days of clear liquids in preparation for the
exam. Please call or consult GI for patients with difficult problems.
MC2937-72revWIPru